August 17, 2018August 16, 2018
An Introduction to a ‘Practical Guide to Life with FA’
A Practical Guide to Life with FA - a Column by Christina Logan, Columns
My name is Christina Logan, and doctors diagnosed me with the rare neuromuscular disorder Friedreich’s ataxia at the ... Read more
August 16, 2018August 16, 2018
Eye Movement and Skeletal Abnormalities Common in Friedreich’s Ataxia Patients, Registry Study Finds
News
A large, European registry study shows that Friedreich’s ataxia patients have a considerable spectrum of clinical symptoms that go ... Read more
August 15, 2018August 14, 2018
The Day I Began Tracking My ‘Little Victories’
Columns, Little Victories - a Column by Matthew Lafleur
In an instant, my plans and dreams vanished; I was left wandering through life with no set future, and ... Read more
August 13, 2018August 10, 2018
How a Television Show Changed My Thought Process
Columns, Fighting FA - a Column by Frankie Perazzola
I often have conversations with others about the mindset and positive outlook I attained while dealing with this illness. ... Read more
August 7, 2018August 7, 2018
Antioxidants Increase Frataxin Levels in Friedreich’s Ataxia Cells, Study Reports
News
Specific antioxidant compounds and derivatives were able to boost levels of the protein frataxin in cells from Friedreich’s ataxia (FA) patients, ... Read more
August 6, 2018August 2, 2018
Birthdays Don’t Have the Same Meaning Anymore, Thanks to FA
Columns, Fighting FA - a Column by Frankie Perazzola
Birthdays used to be so fun for me. Now, though, they are just reminders that this disease is taking ... Read more
August 2, 2018August 2, 2018
Long-term Treatment with EPI-743 May Prevent FA Progression in Patients, Phase 2 Results Show
News
Long-term use of EPI-743 (vatiquinone), an investigational therapy being developed by BioElectron, can improve neurological function and prevent disease progression in Friedreich’s ataxia ... Read more
August 1, 2018August 1, 2018
Discovery in Plants May Help Uncover Genetic Mechanism, Potential Therapies for Friedreich’s Ataxia
News
A discovery made in plants may shed light on the genetic mechanism underlying Friedreich’s ataxia (FA) and open ... Read more
July 26, 2018July 26, 2018
Synthetic Molecules Normalize Frataxin Protein Levels in Cells from FA Patients, Study Reports
News
Synthetic molecules targeting the hallmark gene mutation in Friedreich’s ataxia (FA) were able to restore frataxin protein levels ... Read more
July 24, 2018July 24, 2018
PTC Expanding Gene Therapy Portfolio by Buying Agilis Biotherapeutics
News
PTC Therapeutics announced it will acquire Agilis Biotherapeutics, a company focused on the development of gene therapies targeting rare diseases ... Read more
July 17, 2018July 17, 2018
Atrophy Along Spine and in Specific Brain Areas Linked to Clinical Decline in FA Patients, Study Reports
News
Patients with Friedreich’s ataxia (FA) have smaller spinal cords and evidence of atrophy in specific areas of the ... Read more
July 12, 2018July 12, 2018
Omaveloxolone Receives Orphan Drug Designation for FA from European Medicines Agency
News
Omaveloxolone, Reata Pharmaceuticals’ investigational candidate for the treatment of Friedreich’s ataxia (FA), has been granted orphan drug status ... Read more

August 17, 2018August 16, 2018

An Introduction to a ‘Practical Guide to Life with FA’

A Practical Guide to Life with FA - a Column by Christina Logan, Columns

My name is Christina Logan, and doctors diagnosed me with the rare neuromuscular disorder Friedreich’s ataxia at the age of 21. I grew up in Holland, Pennsylvania, with my ... Read more

August 16, 2018August 16, 2018

Eye Movement and Skeletal Abnormalities Common in Friedreich’s Ataxia Patients, Registry Study Finds

News

A large, European registry study shows that Friedreich’s ataxia patients have a considerable spectrum of clinical symptoms that go beyond the typical neurological ataxia. Common non-neurologic clinical symptoms identified ... Read more

August 15, 2018August 14, 2018

The Day I Began Tracking My ‘Little Victories’

Columns, Little Victories - a Column by Matthew Lafleur

In an instant, my plans and dreams vanished; I was left wandering through life with no set future, and it was scary. I can remember parts of that day ... Read more

August 13, 2018August 10, 2018

How a Television Show Changed My Thought Process

Columns, Fighting FA - a Column by Frankie Perazzola

I often have conversations with others about the mindset and positive outlook I attained while dealing with this illness. Although I realize this may be temporary and my attitude ... Read more

August 7, 2018August 7, 2018

Antioxidants Increase Frataxin Levels in Friedreich’s Ataxia Cells, Study Reports

News

Specific antioxidant compounds and derivatives were able to boost levels of the protein frataxin in cells from Friedreich’s ataxia (FA) patients, according to researchers from Arizona State University in Tempe. Their study, ... Read more

August 6, 2018August 2, 2018

Birthdays Don’t Have the Same Meaning Anymore, Thanks to FA

Columns, Fighting FA - a Column by Frankie Perazzola

Birthdays used to be so fun for me. Now, though, they are just reminders that this disease is taking over my physicality slowly. While I have a positive attitude ... Read more

August 2, 2018August 2, 2018

Long-term Treatment with EPI-743 May Prevent FA Progression in Patients, Phase 2 Results Show

News

Long-term use of EPI-743 (vatiquinone), an investigational therapy being developed by BioElectron, can improve neurological function and prevent disease progression in Friedreich’s ataxia (FA) patients, results from a Phase 2 clinical trial show. ... Read more

August 1, 2018August 1, 2018

Discovery in Plants May Help Uncover Genetic Mechanism, Potential Therapies for Friedreich’s Ataxia

News

A discovery made in plants may shed light on the genetic mechanism underlying Friedreich’s ataxia (FA) and open the door to new ways to treat the disease, a study ... Read more

July 26, 2018July 26, 2018

Synthetic Molecules Normalize Frataxin Protein Levels in Cells from FA Patients, Study Reports

News

Synthetic molecules targeting the hallmark gene mutation in Friedreich’s ataxia (FA) were able to restore frataxin protein levels to normal in cells taken from patients, a study has found. ... Read more

July 24, 2018July 24, 2018

PTC Expanding Gene Therapy Portfolio by Buying Agilis Biotherapeutics

News

PTC Therapeutics announced it will acquire Agilis Biotherapeutics, a company focused on the development of gene therapies targeting rare diseases that affect the central nervous system (CNS). The acquisition will ... Read more

July 17, 2018July 17, 2018

Atrophy Along Spine and in Specific Brain Areas Linked to Clinical Decline in FA Patients, Study Reports

News

Patients with Friedreich’s ataxia (FA) have smaller spinal cords and evidence of atrophy in specific areas of the brain — differences that, in their degree, work to help predict ... Read more

July 12, 2018July 12, 2018

Omaveloxolone Receives Orphan Drug Designation for FA from European Medicines Agency

News

Omaveloxolone, Reata Pharmaceuticals’ investigational candidate for the treatment of Friedreich’s ataxia (FA), has been granted orphan drug status from the European Medicines Agency. The EMA’s decision follows orphan drug designation ... Read more